In recent months, the world has seen unprecedented investment in new vaccines. Yet, while a COVID-19 vaccine proven to be safe and effective may be less than a year away, a new tuberculosis vaccine might only be ready to be rolled out in a decade, despite a massive head start over COVID-19. Amy Green takes a closer look at the race for a new vaccine for the world’s top infectious disease killer.
Early enthusiasm about South Africa’s strong position to scale up COVID-19 testing due to existing investments in diagnostic infrastructure for HIV and TB waned after the country found itself unable to secure adequate test materials. Steps are now being taken to reduce the dependence on just a few suppliers for these materials. Catherine Tomlinson reports.
The Northern Cape Health Department has come under fire from NEHAWU, the DA, residents and healthcare workers for not testing enough and dragging its feet with its COVID-19 response. Refilwe Mekoa and Alicestine October investigate.
Government has rolled out an intensified screening and testing campaign in the hope of finding more COVID-19 cases during and after the lockdown period, but the disparity between the country’s testing capacity and the actual number of tests being conducted remains substantial.
South Africa’s strategy to defeat COVID-19 (Coronavirus Disease 2019) is to lockdown the country and upscale testing to quickly identify individuals who may have been infected with the SARS-CoV-2 virus.